Bio-Connect

Goat anti-KAP1 / TRIM28

EB05810
Everest Biotech
ApplicationsFlow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry
Product group Antibodies
TargetTRIM28
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-KAP1 / TRIM28 Antibody
  • Delivery Days Customer
    5
  • Application Supplier Note
    Immunofluorescence: Strong expression of the protein seen in the nuclei of HeLa and U2OS cells. Recommended concentration: 10microg/ml. Flow Cytometry: Flow cytometric analysis of HeLa cells. Recommended concentration: 10ug/ml.
  • Applications
    Flow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry
  • Applications Supplier
    Pep-ELISA, IF, FC, IHC
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID10155
  • Target name
    TRIM28
  • Target description
    tripartite motif containing 28
  • Target synonyms
    KAP1, PPP1R157, RNF96, TF1B, TIF1B, TIF1beta, WT7, transcription intermediary factor 1-beta, E3 SUMO-protein ligase TRIM28, KAP-1, KRAB [Kruppel-associated box domain]-associated protein 1, KRAB-interacting protein 1, KRIP-1, RING finger protein 96, RING-type E3 ubiquitin transferase TIF1-beta, TIF1-beta, nuclear corepressor KAP-1, protein phosphatase 1, regulatory subunit 157, transcriptional intermediary factor 1-beta
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_005753.1. Purification: Antigen affinity purified. Names and symbols: TRIM28; KAP1; TF1B; RNF96; TIF1B; tripartite motif-containing 28; KRAB-associated protein 1; nuclear corepressor KAP-1; transcriptional intermediary factor 1-beta; FLJ29029; KRAB-associated protein 1; tripartite motif-containing 28 protein
  • Reactivity Supplier
    Human, Mouse
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Yokoe T et al., 2010 Mar, Ann Surg Oncol
    Read more